Patients suffering from Tourette syndrome (TS) report symptomatic benefits following the use of medical cannabis, states new research.
The research was published by the journal Parkinsonism and Related Disorders. During the study researchers surveyed 42 patients with TS who had approval from the Health Ministry to use medical marijuana in Israel. Subjects consistently reported benefits from cannabis consumption including better sleep, reduced tic severity and improved mood. Roughly 75% of participants said that they plan to use cannabis long-term.
“MC (medical cannabis) seems to hold promise in the treatment of GTS (Gilles de la Tourette syndrome) as it demonstrated high subjective satisfaction by most patients”, the study concludes.
The study is titled Single center experience with medical cannabis in Gilles de la Tourette syndrome.